Ian is a strategic and influential Project Manager with a proven 30-year track record collaborating with key stakeholders, senior leadership, and cross-functional teams supporting the regulatory strategy, development and global commercialization of pharmaceutical drug products from phase I through mature supply and spanning a wide variety of therapeutic areas and dosage forms. Ian’s primary expertise is in CMC solid dosage process development and particle engineering. He has supported significant numbers of technology transfers as well as CMC formulation development through to commercial production, working for large multi-nationals such as GSK, GEA and Pfizer, as well as small venture–supported companies entering the health care sector.